Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An update on liquid biopsy analysis for diagnostic and monitoring applications in non-small cell lung cancer.

Expert review of molecular diagnostics - 1 Jan 2018

Mayo-de-Las-Casas Clara, Garzón Ibáñez Mónica, Jordana-Ariza Núria, García-Peláez Beatriz, Balada-Bel Ariadna, Villatoro Sergio, Malapelle Umberto, Karachaliou Niki, Troncone Giancarlo, Rosell Rafael, Molina-Vila Miguel Angel

Abstract excerpt

INTRODUCTION: Collection of tumor samples is not always feasible in non-small cell lung cancer (NSCLC) patients, and circulating free DNA (cfDNA) extracted from blood represents a viable alternative. Different sensitive platforms have been developed for genetic cfDNA testing, some of which are already in clinical use. However, several difficulties remain, particularly the lack of standardization of these...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell-Free Nucleic Acids

Share to DNA, Neoplasm

Share to Drug Resistance, Neoplasm

Share to High-Throughput Nucleotide Sequencing

Share to Liquid Biopsy

Share to Protein Kinase Inhibitors

Source

Identifiers

PMID: 29172773
DOI: 10.1080/14737159.2018.1407243

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An update on liquid biopsy analysis for diagnostic and monitoring applications in non-small cell lung cancer.PMID 29172773Read ↗

Liquid biopsy tracking of lung tumor evolutions over timeSemantic proximity Read ↗

Liquid Biopsy for Disease Monitoring in Non-Small Cell Lung Cancer: The Link between Biology and the Clinic.Semantic proximity Read ↗

Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challengesSemantic proximity Read ↗

Next generation sequencing techniques in liquid biopsy: focus on non-small cell lung cancer patientsSemantic proximity Read ↗

Update on molecular pathology and role of liquid biopsy in nonsmall cell lung cancer.Semantic proximity Read ↗

Mutated circulating tumor DNA as a liquid biopsy in lung cancer detection and treatment.Semantic proximity Read ↗

Clinical Utility of ctDNA Analysis in Lung Cancer—A ReviewSemantic proximity Read ↗

Implementation of Next Generation Sequencing-Based Liquid Biopsy for Clinical Molecular Diagnostics in Non-Small Cell Lung Cancer (NSCLC) PatientsSemantic proximity Read ↗

The Emerging Role of "Liquid Biopsies," Circulating Tumor Cells, and Circulating Cell-Free Tumor DNA in Lung Cancer Diagnosis and Identification of Resistance Mutations.Semantic proximity Read ↗

Liquid biopsy and its role in an advanced clinical trial for lung cancer.Semantic proximity Read ↗

Validation and comparison of two NGS assays for the detection of EGFR T790M resistance mutation in liquid biopsies of NSCLC patientsSemantic proximity Read ↗

Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.